Human monoclonal HLA antibodies reveal interspecies crossreactive swine MHC class I epitopes relevant for xenotransplantation-Reference-Cited by-同舟云学术

Human monoclonal HLA antibodies reveal interspecies crossreactive swine MHC class I epitopes relevant for xenotransplantation

Published:2010-01 Issue:4 Volume:47 Page:809-815
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Mulder Arend,Kardol Marrie J.,Arn J. Scott,Eijsink Chantal,Franke Marry E.I.,Schreuder Geziena M.T.,Haasnoot Geert W.,Doxiadis Ilias I.N.,Sachs David H.,Smith Douglas M.,Claas Frans H.J.

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference23 articles.

1. Utility of xenografts: lack of correlation between PRA and natural antibodies to swine;Bartholomew;Xenotransplantation,1997

2. Automated reading of HLA-A,B,C typing and screening. The propidium iodide (PI) method;Bruning;Hum. Immunol.,1982

3. Acceptable HLA mismatches for highly immunized patients;Claas;Rev. Immunogenet.,1999

4. The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome;Claas;Transplantation,2004

5. Alloantibody and xenoantibody cross-reactivity in transplantation;Cooper;Transplantation,2004

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Other Non-α1,3Gal Antigens;Glycoimmunology in Xenotransplantation;2024

2. Human leukocyte antigen class I antibody-activated endothelium promotes CD206+ M2 macrophage polarization and MMP9 secretion through TLR4 signaling and P-selectin in a model of antibody-mediated rejection and allograft vasculopathy;American Journal of Transplantation;2023-10

3. Retina-arrestin specific CD8+ T cells are not implicated in HLA-A29-positive birdshot chorioretinitis;Clinical Immunology;2023-02

4. The respective relevance of sensitization to alloantigens and xenoantigens in pig organ xenotransplantation;Human Immunology;2023-01

5. Gentechnisch veränderte Großtiere in der Biomedizin;Biotechnologie bei Nutztieren 2;2023